Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies

Dirk J. Lefeber, Johannes Schönberger, Eva Morava-Kozicz, Mailys Guillard, Karin M. Huyben, Kiek Verrijp, Olga Grafakou, Athanasios Evangeliou, Frank W. Preijers, Panagiota Manta, Jef Yildiz, Stephanie Grünewald, Martha Spilioti, Christa van den Elzen, Dominique Klein, Daniel Hess, Hisashi Ashida, Jan Hofsteenge, Yusuke Maeda, Lambert van den HeuvelMartin Lammens, Ludwig Lehle, Ron A. Wevers

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Alpha-dystroglycanopathies such as Walker Warburg syndrome represent an important subgroup of the muscular dystrophies that have been related to defective O-mannosylation of alpha-dystroglycan. In many patients, the underlying genetic etiology remains unsolved. Isolated muscular dystrophy has not been described in the congenital disorders of glycosylation (CDG) caused by N-linked protein glycosylation defects. Here, we present a genetic N-glycosylation disorder with muscular dystrophy in the group of CDG type I. Extensive biochemical investigations revealed a strongly reduced dolichol-phosphate-mannose (Dol-P-Man) synthase activity. Sequencing of the three DPM subunits and complementation of DPM3-deficient CHO2.38 cells showed a pathogenic p.L85S missense mutation in the strongly conserved coiled-coil domain of DPM3 that tethers catalytic DPM1 to the ER membrane. Cotransfection experiments in CHO cells showed a reduced binding capacity of DPM3(L85S) for DPM1. Investigation of the four Dol-P-Man-dependent glycosylation pathways in the ER revealed strongly reduced O-mannosylation of alpha-dystroglycan in a muscle biopsy, thereby explaining the clinical phenotype of muscular dystrophy. This mild Dol-P-Man biosynthesis defect due to DPM3 mutations is a cause for alpha-dystroglycanopathy, thereby bridging the congenital disorders of glycosylation with the dystroglycanopathies.

Original languageEnglish (US)
Pages (from-to)76-86
Number of pages11
JournalAmerican Journal of Human Genetics
Volume85
Issue number1
DOIs
StatePublished - Jul 10 2009
Externally publishedYes

Fingerprint

Congenital Disorders of Glycosylation
Muscular Dystrophies
Walker-Warburg Syndrome
Dolichol Phosphates
Glycosylation
Dystroglycans
Mannose
CHO Cells
Missense Mutation
Phenotype
Biopsy
Muscles
Mutation
Membranes
dolichyl-phosphate beta-D-mannosyltransferase

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies. / Lefeber, Dirk J.; Schönberger, Johannes; Morava-Kozicz, Eva; Guillard, Mailys; Huyben, Karin M.; Verrijp, Kiek; Grafakou, Olga; Evangeliou, Athanasios; Preijers, Frank W.; Manta, Panagiota; Yildiz, Jef; Grünewald, Stephanie; Spilioti, Martha; van den Elzen, Christa; Klein, Dominique; Hess, Daniel; Ashida, Hisashi; Hofsteenge, Jan; Maeda, Yusuke; van den Heuvel, Lambert; Lammens, Martin; Lehle, Ludwig; Wevers, Ron A.

In: American Journal of Human Genetics, Vol. 85, No. 1, 10.07.2009, p. 76-86.

Research output: Contribution to journalArticle

Lefeber, DJ, Schönberger, J, Morava-Kozicz, E, Guillard, M, Huyben, KM, Verrijp, K, Grafakou, O, Evangeliou, A, Preijers, FW, Manta, P, Yildiz, J, Grünewald, S, Spilioti, M, van den Elzen, C, Klein, D, Hess, D, Ashida, H, Hofsteenge, J, Maeda, Y, van den Heuvel, L, Lammens, M, Lehle, L & Wevers, RA 2009, 'Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies', American Journal of Human Genetics, vol. 85, no. 1, pp. 76-86. https://doi.org/10.1016/j.ajhg.2009.06.006
Lefeber, Dirk J. ; Schönberger, Johannes ; Morava-Kozicz, Eva ; Guillard, Mailys ; Huyben, Karin M. ; Verrijp, Kiek ; Grafakou, Olga ; Evangeliou, Athanasios ; Preijers, Frank W. ; Manta, Panagiota ; Yildiz, Jef ; Grünewald, Stephanie ; Spilioti, Martha ; van den Elzen, Christa ; Klein, Dominique ; Hess, Daniel ; Ashida, Hisashi ; Hofsteenge, Jan ; Maeda, Yusuke ; van den Heuvel, Lambert ; Lammens, Martin ; Lehle, Ludwig ; Wevers, Ron A. / Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies. In: American Journal of Human Genetics. 2009 ; Vol. 85, No. 1. pp. 76-86.
@article{717d31370b9f40038e0fae85639c7c7d,
title = "Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies",
abstract = "Alpha-dystroglycanopathies such as Walker Warburg syndrome represent an important subgroup of the muscular dystrophies that have been related to defective O-mannosylation of alpha-dystroglycan. In many patients, the underlying genetic etiology remains unsolved. Isolated muscular dystrophy has not been described in the congenital disorders of glycosylation (CDG) caused by N-linked protein glycosylation defects. Here, we present a genetic N-glycosylation disorder with muscular dystrophy in the group of CDG type I. Extensive biochemical investigations revealed a strongly reduced dolichol-phosphate-mannose (Dol-P-Man) synthase activity. Sequencing of the three DPM subunits and complementation of DPM3-deficient CHO2.38 cells showed a pathogenic p.L85S missense mutation in the strongly conserved coiled-coil domain of DPM3 that tethers catalytic DPM1 to the ER membrane. Cotransfection experiments in CHO cells showed a reduced binding capacity of DPM3(L85S) for DPM1. Investigation of the four Dol-P-Man-dependent glycosylation pathways in the ER revealed strongly reduced O-mannosylation of alpha-dystroglycan in a muscle biopsy, thereby explaining the clinical phenotype of muscular dystrophy. This mild Dol-P-Man biosynthesis defect due to DPM3 mutations is a cause for alpha-dystroglycanopathy, thereby bridging the congenital disorders of glycosylation with the dystroglycanopathies.",
author = "Lefeber, {Dirk J.} and Johannes Sch{\"o}nberger and Eva Morava-Kozicz and Mailys Guillard and Huyben, {Karin M.} and Kiek Verrijp and Olga Grafakou and Athanasios Evangeliou and Preijers, {Frank W.} and Panagiota Manta and Jef Yildiz and Stephanie Gr{\"u}newald and Martha Spilioti and {van den Elzen}, Christa and Dominique Klein and Daniel Hess and Hisashi Ashida and Jan Hofsteenge and Yusuke Maeda and {van den Heuvel}, Lambert and Martin Lammens and Ludwig Lehle and Wevers, {Ron A.}",
year = "2009",
month = "7",
day = "10",
doi = "10.1016/j.ajhg.2009.06.006",
language = "English (US)",
volume = "85",
pages = "76--86",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies

AU - Lefeber, Dirk J.

AU - Schönberger, Johannes

AU - Morava-Kozicz, Eva

AU - Guillard, Mailys

AU - Huyben, Karin M.

AU - Verrijp, Kiek

AU - Grafakou, Olga

AU - Evangeliou, Athanasios

AU - Preijers, Frank W.

AU - Manta, Panagiota

AU - Yildiz, Jef

AU - Grünewald, Stephanie

AU - Spilioti, Martha

AU - van den Elzen, Christa

AU - Klein, Dominique

AU - Hess, Daniel

AU - Ashida, Hisashi

AU - Hofsteenge, Jan

AU - Maeda, Yusuke

AU - van den Heuvel, Lambert

AU - Lammens, Martin

AU - Lehle, Ludwig

AU - Wevers, Ron A.

PY - 2009/7/10

Y1 - 2009/7/10

N2 - Alpha-dystroglycanopathies such as Walker Warburg syndrome represent an important subgroup of the muscular dystrophies that have been related to defective O-mannosylation of alpha-dystroglycan. In many patients, the underlying genetic etiology remains unsolved. Isolated muscular dystrophy has not been described in the congenital disorders of glycosylation (CDG) caused by N-linked protein glycosylation defects. Here, we present a genetic N-glycosylation disorder with muscular dystrophy in the group of CDG type I. Extensive biochemical investigations revealed a strongly reduced dolichol-phosphate-mannose (Dol-P-Man) synthase activity. Sequencing of the three DPM subunits and complementation of DPM3-deficient CHO2.38 cells showed a pathogenic p.L85S missense mutation in the strongly conserved coiled-coil domain of DPM3 that tethers catalytic DPM1 to the ER membrane. Cotransfection experiments in CHO cells showed a reduced binding capacity of DPM3(L85S) for DPM1. Investigation of the four Dol-P-Man-dependent glycosylation pathways in the ER revealed strongly reduced O-mannosylation of alpha-dystroglycan in a muscle biopsy, thereby explaining the clinical phenotype of muscular dystrophy. This mild Dol-P-Man biosynthesis defect due to DPM3 mutations is a cause for alpha-dystroglycanopathy, thereby bridging the congenital disorders of glycosylation with the dystroglycanopathies.

AB - Alpha-dystroglycanopathies such as Walker Warburg syndrome represent an important subgroup of the muscular dystrophies that have been related to defective O-mannosylation of alpha-dystroglycan. In many patients, the underlying genetic etiology remains unsolved. Isolated muscular dystrophy has not been described in the congenital disorders of glycosylation (CDG) caused by N-linked protein glycosylation defects. Here, we present a genetic N-glycosylation disorder with muscular dystrophy in the group of CDG type I. Extensive biochemical investigations revealed a strongly reduced dolichol-phosphate-mannose (Dol-P-Man) synthase activity. Sequencing of the three DPM subunits and complementation of DPM3-deficient CHO2.38 cells showed a pathogenic p.L85S missense mutation in the strongly conserved coiled-coil domain of DPM3 that tethers catalytic DPM1 to the ER membrane. Cotransfection experiments in CHO cells showed a reduced binding capacity of DPM3(L85S) for DPM1. Investigation of the four Dol-P-Man-dependent glycosylation pathways in the ER revealed strongly reduced O-mannosylation of alpha-dystroglycan in a muscle biopsy, thereby explaining the clinical phenotype of muscular dystrophy. This mild Dol-P-Man biosynthesis defect due to DPM3 mutations is a cause for alpha-dystroglycanopathy, thereby bridging the congenital disorders of glycosylation with the dystroglycanopathies.

UR - http://www.scopus.com/inward/record.url?scp=67649584051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649584051&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2009.06.006

DO - 10.1016/j.ajhg.2009.06.006

M3 - Article

C2 - 19576565

AN - SCOPUS:67649584051

VL - 85

SP - 76

EP - 86

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -